Institutional shares held 1.87 Billion
17.3M calls
14.8M puts
Total value of holdings $238B
$2.21B calls
$1.89B puts
Market Cap $324B
2,533,280,000 Shares Out.
Institutional ownership 73.67%
# of Institutions 3,771


Latest Institutional Activity in MRK

Top Purchases

Q2 2024
Sg Americas Securities, LLC Shares Held: 1.04M ($133M)
Q2 2024
Bdf Gestion Shares Held: 97K ($12.4M)
Q2 2024
Simplicity Wealth,Llc Shares Held: 191K ($24.4M)
Q2 2024
Annex Advisory Services, LLC Shares Held: 269K ($34.3M)
Q2 2024
Nbc Securities, Inc. Shares Held: 47.6K ($6.08M)

Top Sells

Q2 2024
Amf Tjanstepension Ab Shares Held: 375K ($47.9M)
Q2 2024
Value Partners Investments Inc. Shares Held: 15.3K ($1.95M)
Q2 2024
Boston Common Asset Management, LLC Shares Held: 213K ($27.2M)
Q2 2024
Jackson Wealth Management, LLC Shares Held: 27.7K ($3.53M)
Q2 2024
Douglas Lane & Associates, LLC Shares Held: 511K ($65.3M)

About MRK

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.


Insider Transactions at MRK

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
666K Shares
From 22 Insiders
Grant, award, or other acquisition 233K shares
Exercise of conversion of derivative security 433K shares
Sell / Disposition
499K Shares
From 15 Insiders
Payment of exercise price or tax liability 35.1K shares
Open market or private sale 464K shares

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Track Activities on MRK